• Novartis hands investors Alcon spin-off and $5 billion share buyback

    4 monthes ago - By Reuters

    ZURICH - Novartis plans to spin off its Alcon eye care business to shareholders and repurchase up to $5 billion in shares, as Chief Executive Vas Narasimhan refocuses the Swiss firm on prescription drugs.
    Read more ...

     

  • Novartis to spin off Alcon, will buy back $5 billion in shares

    4 monthes ago - By Reuters

    ZURICH - Novartis unveiled its long-expected plan to spin off all of its Alcon eye care devices business and launch a share buyback of up to $5 billion as the company sharpens its focus on prescription drugs, it said on Friday.
    Read more ...